Document:

exv10w9

 

Exhibit 10.9

EXHIBIT D TO THE NON-QUALIFIED STOCK OPTION GRANT NOTICE

TERMS AND CONDITIONS

ADDENDUM FOR EMPLOYEES IN THE 

KINGDOM OF THAILAND

May 2008

     Pursuant to the Non-Qualified Stock Option Grant Notice to which this addendum is attached
(the “Grant Notice”), Allergan, Inc. (the “Company”) granted to the participant specified on the
Grant Notice (“Participant”) an option under the Allergan, Inc. 2008 Incentive Award Plan
(the “Plan”) to purchase the number of shares of the Company’s common stock, par value $0.01 per
share (“Stock”), indicated in the Grant Notice, subject to a general set of terms and conditions
attached as “Exhibit A” to the Grant Notice (the “Terms”), the terms and conditions of the Grant
Notice and the Plan, and the terms and conditions set forth in this addendum. The provisions of
this addendum form an integral part of the Terms. The provisions of the Plan, the Grant Notice and
the Terms that do not contradict the provisions of this addendum shall remain applicable.

     Capitalized terms not specifically defined herein shall have the meanings specified in the
Plan.

	1.	 	Broker-Assisted Cashless Exercise Required. Notwithstanding anything to the contrary in
Section 4.4 or Section 4.5 of the Terms, payment of the exercise price and all amounts
required to be withheld by the Company or any Subsidiary shall be made solely by delivery of a
notice that Participant has placed a market sell order with a broker with respect to shares of
Stock then issuable upon exercise of the Option, and that the broker has been directed to pay
a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the
aggregate exercise price; provided, that payment of such proceeds is then made to the Company
upon settlement of such sale. The certificates for the shares of Stock purchased shall be
delivered directly to the brokerage firm for the purpose of completing the sale transaction.
	 
	2.	 	Exercise Restrictions. The Option shall not be exercisable on any day on which the option
exercise price per share exceeds the Fair Market Value.
	 
	3.	 	Certificates. The Company shall not be required to provide Participant with certificates for
any shares of Stock for which the Option is exercised.
	 
	4.	 	Currency. All calculations under the Plan shall be prepared based on U.S. dollars. Amounts
denominated in any currency other than U.S. dollars shall be converted into U.S. dollars on
the basis of the Exchange Rate in effect on the relevant date. The “Exchange Rate” shall be
the rate at which the relevant currency is converted into U.S. Dollars, as reported on the
relevant date in The Wall Street Journal (or such other reliable source as may be selected
from time to time by the Administrator in its discretion).
	 
	5.	 	Compliance with Legal Requirements. Sections 1, 2 and 3 are intended to satisfy the
applicable legal requirements of the Kingdom of Thailand, and the regulations and rulings
thereunder (the “Thai Legal Requirements”), and shall be interpreted and administered
in accordance therewith. Sections 1, 2 and 3 shall terminate and cease to be binding and
shall have no force or effect in the event of any amendment or modification to the Thai Legal
Requirements
permitting Participant to purchase and own shares of Stock, as determined by the Company in
its sole and absolute discretion.
	 
	6.	 	Other Terms. The provisions of this Terms and Conditions Addendum for Employees in the
Kingdom of Thailand shall supersede any provisions to the contrary in the Grant Notice, the
Terms or the Plan.exv10w10

 

Exhibit 10.10

NON-EMPLOYEE DIRECTOR

RESTRICTED STOCK AWARD GRANT NOTICE

     Pursuant to the Allergan, Inc. 2008 Incentive Award Plan (the “Plan”), Allergan, Inc. (the
“Company”) hereby grants to the individual listed below (“Participant”) the number of shares of the
Company’s common stock, par value US$0.01 per share (“Stock”), set forth below (the “Shares”).
This Restricted Stock award is subject to all of the terms and conditions set forth herein, in the
Restricted Stock Award Agreement attached hereto as Exhibit A (the “Restricted Stock
Agreement”) and in the Plan, each of which is incorporated herein by reference. Unless otherwise
defined herein, the terms defined in the Plan shall have the same defined meanings in this
Restricted Stock Award Grant Notice (the “Grant Notice”).

	 	 	 	 	 
	Participant:
	 	 	 	 
	Grant Date:

	 	 

	 	 
	Total Number of

	 	 

	 	 
	Shares of Restricted Stock:

	 	 

	 	 

	 	 	 	 	 	 	 
	Vesting Schedule:	 	Subject to the terms and conditions of the Plan, this Grant
Notice and the Restricted Stock Agreement, the Company’s
Forfeiture Restriction (as defined in the Restricted Stock
Agreement) shall lapse as to 4,800 Shares, as adjusted
pursuant to Section 11.1 of the Plan, each calendar year upon
the earlier to occur of:
	 
	 	 	 	 	 	 
	 

	 	 	 	(i)
	 	the first anniversary of the Grant Date, or
	 
	 	 	 	 	 	 
	 

	 	 	 	(ii)
	 	the annual meeting held during such calendar year at
which one or more members of the Board are standing for
re-election.
	 
	 	 	 	 	 	 
	 	 	In no event, however, shall the Forfeiture Restriction (as
defined in the Restricted Stock Agreement) lapse as to any
additional Shares following Participant’s termination of
service as a Director of the Company, except as may otherwise
be provided by the Administrator or as set forth in a written
agreement between the Company and Participant.

Remainder of page intentionally left blank.

 

 

     By his or her signature below, Participant agrees to be bound by the terms and conditions of
the Plan, the Restricted Stock Agreement and this Grant Notice. Participant has reviewed the
Restricted Stock Agreement, the Plan and this Grant Notice in their entirety, has had an
opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully
understands all provisions of this Grant Notice, the Restricted Stock Agreement and the Plan.
Participant hereby agrees to accept as binding, conclusive and final all decisions and
interpretations of the Administrator arising under the Plan, this Grant Notice or the Restricted
Stock Agreement or relating to the Shares.

	 	 	 	 	 	 	 	 	 
	ALLERGAN, INC.:	 	PARTICIPANT:	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	 	 	By:	 	 	 	 
	Print Name:

	 	 

	 	Print Name:
	 	 

	 	 
	Title:

	 	 

	 	 	 	 

	 	 
	 

	 	 

	 	 	 	
	 	 
	Address:

	 	2525 Dupont Drive
	 	Address:	 	 	 	 
	 

	 	Irvine, California 92612
	 	 	 	 

	 	 
	 

	 	 	 	 	 	 

	 	 

			
	Attachments:	 	Restricted Stock Award Agreement (Exhibit A)

Allergan, Inc. 2008 Incentive Award Plan (Exhibit B)

Allergan, Inc. 2008 Incentive Award Plan Prospectus (Exhibit C)

-2-

 

NON-EMPLOYEE DIRECTOR

EXHIBIT A TO THE RESTRICTED STOCK AWARD GRANT NOTICE

RESTRICTED STOCK AWARD AGREEMENT

May 2008

     Pursuant to the Restricted Stock Award Grant Notice (the “Grant Notice”) to which this
Restricted Stock Award Agreement (this “Agreement”) is attached, Allergan, Inc. (the “Company”)
granted to the participant (“Participant”) specified on the Grant Notice a restricted stock award
under the Allergan, Inc. 2008 Incentive Award Plan (the “Plan”) for the number of shares of the
Company’s common stock, par value US$0.01 per share (“Stock”), indicated in the Grant Notice (the
“Shares”), subject to the terms and conditions of the Grant Notice, this Agreement and the Plan.

I. GENERAL

     1.1 Defined Terms. Capitalized terms not specifically defined herein shall have the
meanings specified in the Grant Notice or, if not defined therein, the Plan.

     1.2 Incorporation of Terms of Plan. The Shares are subject to the terms and
conditions of the Plan, which are incorporated herein by reference.

II. GRANT OF RESTRICTED STOCK

     2.1 Grant of Restricted Stock. In consideration of Participant’s past and/or
continued service to the Company or its Subsidiaries and for other good and valuable consideration,
effective as of the grant date specified on the Grant Notice (the “Grant Date”), the Company hereby
agrees to issue the Shares to Participant, upon the terms and conditions set forth in the Plan, the
Grant Notice and this Agreement.

     2.2 Issuance of Shares. The issuance of the Shares under this Agreement shall occur
at the principal office of the Company simultaneously with the execution of the Grant Notice by the
parties or on such other date as the Company and Participant shall agree (the “Issuance Date”).
Subject to Section 2.3, the Company shall issue the Shares (which shall be issued in Participant’s
name) on the Issuance Date.

     2.3 Conditions to Issuance of Stock Certificates. The Shares, or any portion thereof,
may be either previously authorized but unissued shares or issued shares which have then been
reacquired by the Company. Such Shares shall be fully paid and nonassessable. The Company shall
not be required to issue or deliver any Shares prior to fulfillment of all of the following
conditions:

          (a) The admission of such Shares to listing on all stock exchanges on which such Stock is then
listed;

          (b) The completion of any registration or other qualification of such shares under any state
or federal law or under rulings or regulations of the Securities and Exchange Commission or of any
other governmental regulatory body, which the Administrator shall, in its sole and absolute
discretion, deem necessary or advisable;

          (c) The obtaining of any approval or other clearance from any state or federal governmental
agency which the Administrator shall, in its sole and absolute discretion, determine to be
necessary or advisable;

 

 

     (d) The lapse of such reasonable period of time following the Issuance Date as the
Administrator may from time to time establish for reasons of administrative convenience; and

     (e) The receipt by the Company of full payment for such shares, including payment of all
amounts which, under federal, state or local tax law, the Company (or other Subsidiary) is required
to withhold upon issuance of such Shares.

     2.4 Rights as Stockholder. Except as otherwise provided in Section 3.6 or elsewhere
in this Agreement, upon issuance of the Shares, Participant shall have all the rights of a
stockholder with respect to the Shares, including the right to vote the Shares and to receive all
dividends or other distributions paid or made with respect to the Shares.

     2.5 Escrow. Until the Forfeiture Restriction (as defined in Section 3.1) and all of
the restrictions on transfer imposed pursuant to this Agreement lapse or are removed, the
Administrator may require the certificate(s) representing the Unreleased Shares (as defined in
Section 3.4) to be deposited with the Secretary of the Company, or such other escrow holder as the
Administrator may appoint, as Participant’s attorney-in-fact to sell, assign and transfer unto the
Company, such Unreleased Shares, if any, forfeited pursuant to Section 3.1.

III. RESTRICTIONS ON SHARES

     3.1 Forfeiture Restriction. Subject to the provisions of Section 3.2 and Section 3.3,
upon Participant’s termination of service as a Director of the Company for any or no reason, all of
the Unreleased Shares shall thereupon be forfeited immediately and without any further action by
the Company (the “Forfeiture Restriction”). Upon the occurrence of such a forfeiture, the Company
shall become the legal and beneficial owner of the Shares being forfeited and all rights and
interests therein or relating thereto, and the Company shall have the right to retain and transfer
to its own name the number of Shares being forfeited by Participant. In the event any of the
Unreleased Shares are forfeited under this Section 3.1, any cash, cash equivalents, assets or
securities received by or distributed to Participant with respect to, in exchange for or in
substitution of such Shares and held by the escrow agent pursuant to Section 2.5 and Section 3.6
shall be promptly transferred by the escrow agent to the Company.

     3.2 Release of Shares from Forfeiture Restriction. The Shares shall be released from
the Forfeiture Restriction as indicated in the Grant Notice and Section 3.3 below. Any of the
Shares released from the Forfeiture Restriction shall thereupon be released from the restrictions
on transfer under Section 3.5. In the event any of the Shares are released from the Forfeiture
Restriction, any dividends or other distributions paid on such Shares and held by the escrow agent
pursuant to Section 2.5 and Section 3.6 shall be promptly paid by the escrow agent to Participant.

     3.3 Accelerated Vesting. Notwithstanding anything to the contrary in Section 3.2 or
the Grant Notice, the Shares shall be released from the Forfeiture Restriction on an accelerated
basis under the following circumstances:

          (a) if Participant’s termination of service as a Director of the Company occurs by reason of
Participant’s death or permanent and total disability (within the meaning of Section 22(e)(3) of
the Internal Revenue Code of 1986, as amended (the “Code”)), then the Shares shall be released from
the Forfeiture Restriction immediately prior to Participant’s termination of service as a Director
of the Company; and

A-2

 

          (b) if a Change in Control occurs prior to Participant’s termination of service as a Director
of the Company, then the Shares shall be released from the Forfeiture Restriction immediately prior
to the occurrence of such Change in Control.

     3.4 Unreleased Shares. Any of the Shares which, from time to time, have not yet been
released from the Forfeiture Restriction are referred to herein as “Unreleased Shares.”

     3.5 Restrictions on Transfer.

          (a) Subject to Section 3.5(b), no Unreleased Shares or any dividends or other distributions
thereon or any interest or right therein or part thereof shall be liable for the debts, contracts
or engagements of Participant or Participant’s successors in interest or shall be subject to sale
or other disposition by transfer, alienation, anticipation, pledge, hypothecation, encumbrance,
assignment or any other means whether such sale or other disposition be voluntary or involuntary or
by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable
proceedings (including bankruptcy), and any attempted sale or other disposition thereof shall be
null and void and of no effect, except to the extent that such disposition is permitted by the
preceding sentence.

          (b) Notwithstanding any other provision of this Agreement, with the consent of the
Administrator, the Unreleased Shares may be transferred to one or more “Permitted Transferees” (as
defined below), subject to the following terms and conditions:

          (i) the Unreleased Shares shall not be assignable or transferable by the Permitted
Transferee other than by will or the laws of descent and distribution;

          (ii) the Unreleased Shares shall continue to be subject to all the terms and conditions
of the Plan and this Agreement, as amended from time to time, as applicable to Participant
(other than the ability to further transfer the Unreleased Shares); and

          (iii) Participant and the Permitted Transferee execute any and all documents requested
by the Company, including, without limitation documents to (A) confirm the status of the
transferee as a Permitted Transferee, (B) satisfy any requirements for an exemption for the
transfer under applicable federal and state securities laws, and (C) evidence the transfer.

“Permitted Transferee” means, with respect to Participant, any child, stepchild, grandchild,
parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive
relationships, any person sharing Participant’s household (other than a tenant or employee), a
trust in which these persons have more than 50% of the beneficial interest, any other entity in
which these persons (or Participant) own more than 50% of the voting interests, or any other
transferee specifically approved by the Administrator.

     3.6 Restrictions on Distributions, etc. In the event of any dividend or other
distribution (whether in the form of cash, Stock, other securities or other property, but excluding
money paid as a regular cash dividend), recapitalization, reclassification, stock split, reverse
stock split, reorganization, merger, consolidation, split-up, spin off, combination, repurchase,
liquidation, dissolution, or sale, transfer, exchange or other disposition of all or substantially
all of the assets of the Company, or exchange of Stock or other securities of the Company, issuance
of warrants or other rights to purchase Stock or other securities of the Company, or other similar
corporate transaction or event that affects the Stock, then any new or additional or different
shares or securities or property (including cash) which is paid, issued, exchanged or distributed
in respect of Shares then subject to the Forfeiture Restriction shall be subject to the Forfeiture
Restriction and the restrictions on transfer set forth in Section 3.5 and shall be considered to

A-3

 

be Unreleased Shares, until such restrictions on the underlying Shares lapse or are removed
pursuant to this Agreement (or, if such Shares are no longer outstanding, until such time as such
Shares would have been released from the Forfeiture Restriction pursuant to this Agreement). The
Administrator may require any new or additional or different shares or securities or property
(including cash) considered to be Unreleased Shares pursuant to this Section 3.6 to be deposited
with the Secretary of the Company, or such other escrow holder as the Administrator may appoint, as
Participant’s attorney-in-fact to sell, assign and transfer unto the Company, such new or
additional or different shares or securities or property (including cash) considered to be
Unreleased Shares pursuant to this Section 3.6, if any, forfeited pursuant to Section 3.1.
Notwithstanding the foregoing, nothing herein shall limit the ability of the Administrator to
adjust Unreleased Shares or make other adjustments to the terms and conditions of this Agreement in
accordance with the provisions of Section 11.1 of the Plan.

IV. OTHER PROVISIONS

     4.1 Administration. The Administrator shall have the power to interpret the Plan and
this Agreement and to adopt such rules for the administration, interpretation and application of
the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions
taken and all interpretations and determinations made by the Administrator in good faith shall be
binding, conclusive and final upon Participant, the Company and all other interested persons. No
member of the Administrator shall be personally liable for any action, determination or
interpretation made in good faith with respect to the Plan, this Agreement or the Shares.

     4.2 Taxes. Participant has reviewed with Participant’s own tax advisors the federal,
state, local and foreign tax consequences of this investment and the transactions contemplated by
the Grant Notice and this Agreement. Participant is relying solely on such advisors and not on any
statements or representations of the Company or any of its agents. Participant understands that
Participant (and not the Company) shall be responsible for Participant’s own tax liability that may
arise as a result of this investment or the transactions contemplated by this Agreement.
Participant understands that Participant will recognize ordinary income for federal income tax
purposes under Section 83 of the Code as the restrictions applicable to the Unreleased Shares
lapse. In this context, “restriction” includes the Forfeiture Restriction. Participant
understands that Participant may elect to be taxed for federal income tax purposes at the time the
Shares are issued rather than as and when the Forfeiture Restriction lapses by filing an election
under Section 83(b) of the Code with the Internal Revenue Service no later than 30 days following
the date of purchase.

     PARTICIPANT ACKNOWLEDGES THAT IT IS PARTICIPANT’S SOLE RESPONSIBILITY AND NOT THE COMPANY’S TO
TIMELY FILE THE ELECTION UNDER SECTION 83(b), EVEN IF PARTICIPANT REQUESTS THE COMPANY OR ITS
REPRESENTATIVES TO MAKE THIS FILING ON PARTICIPANT’S BEHALF.

     4.3 Restrictive Legends and Stop-Transfer Orders.

          (a) In order to enforce the Forfeiture Restriction and the other restrictions set forth in the
Plan and this Agreement, the Administrator may cause one or more legends referencing the Forfeiture
Restriction and other restrictions, and any other legend(s) that may be required by applicable
federal, state or foreign securities laws, to be placed on the certificate(s) evidencing the
Shares.

          (b) Participant agrees that, in order to ensure compliance with the restrictions referred to
herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if
any, and that, if the Company transfers its own securities, it may make appropriate notations to
the same effect in its own records.

A-4

 

          (c) The Company shall not be required: (i) to transfer on its books any Shares that have been
sold or otherwise transferred in violation of any of the provisions of this Agreement, or (ii) to
treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or
other transferee to whom such shares shall have been so transferred.

     4.4 No Right to Continue in Service. Nothing in the Plan or this Agreement shall
confer upon Participant any right to continue in service as a member of the Board of Directors of
the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the
Company and its stockholders (or of a Subsidiary and its stockholders, as the case may be), which
rights are hereby expressly reserved, to discharge or terminate Participant’s services at any time
for any reason whatsoever, with or without cause.

     4.5 Notices. All notices or other communications required or permitted hereunder
shall be in writing, and shall be deemed duly given only when delivered in person or when sent by
certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or
branch post office regularly maintained by the United States Postal Service, addressed as follows:

	 	 	 	 	 
	 

	 	If to the Company:
	 	Allergan, Inc.

Attention: General Counsel

2525 Dupont Drive

Irvine, California 92612

	 
	 	 	 	 
	 

	 	If to Participant:
	 	To Participant’s most recent address
then on file in the Company’s personnel records.

By a notice given pursuant to this Section 4.5, either party may thereafter designate a different
address for notices to be given to that party.

     4.6 Titles. Titles are provided herein for convenience only and are not to serve as a
basis for interpretation or construction of this Agreement.

     4.7 Governing Law; Severability. This Agreement shall be administered, interpreted
and enforced under the laws of the State of Delaware, without regard to conflicts of law principles
thereof. Should any provision of this Agreement be determined by a court of law to be illegal or
unenforceable, the other provisions shall nevertheless remain effective and shall remain
enforceable.

     4.8 Conformity to Securities Laws. Participant acknowledges that the Plan is intended
to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act
and any and all regulations and rules promulgated by the Securities and Exchange Commission
thereunder, and state and foreign securities laws and regulations. Notwithstanding anything herein
to the contrary, the Plan shall be administered, and the Shares are to be issued, only in such a
manner as to conform to such laws, rules and regulations. To the extent permitted by applicable
law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such
laws, rules and regulations.

     4.9 Amendments. To the extent permitted by the Plan, this Agreement may be wholly or
partially amended or otherwise modified, suspended or terminated at any time or from time to time
by the Administrator; provided, that, except as may otherwise be provided by the Plan, no
termination, amendment, or modification of this Agreement shall adversely affect the Shares in any
material way without Participant’s prior written consent. This Agreement may not be modified,
suspended or
terminated except by an instrument in writing signed by a duly authorized representative of
the Company and, if Participant’s consent is required, by Participant.

A-5

 

     4.10 Successors and Assigns. The Company may assign any of its rights under this
Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the
successors and assigns of the Company. Subject to the restrictions on transfer set forth in
Section 3.5, this Agreement shall be binding upon Participant and Participant’s heirs, executors,
administrators, successors and assigns.

     4.11 Section 16. Notwithstanding any other provision of the Plan or this Agreement,
the Shares and this Agreement shall be subject to any additional limitations set forth in any
applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule
16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To
the extent permitted by applicable law, this Agreement shall be deemed amended to the extent
necessary to conform to such applicable exemptive rule.

     4.12 Entire Agreement. The Plan and this Agreement constitute the entire agreement of
the parties and supersede in their entirety all prior undertakings and agreements of the Company
and Participant with respect to the subject matter hereof.

A-6

 

EXHIBIT B TO THE RESTRICTED STOCK AWARD GRANT NOTICE

ALLERGAN, INC. 2008 INCENTIVE AWARD PLAN

 

 

EXHIBIT C TO THE RESTRICTED STOCK AWARD GRANT NOTICE

ALLERGAN, INC. 2008 INCENTIVE AWARD PLAN PROSPECTUS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]